SchauerSurgeryforTDM糖尿病脂肪肝-培训课件.pptVIP

SchauerSurgeryforTDM糖尿病脂肪肝-培训课件.ppt

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Adverse Events through 36 Months No Difference Between Groups BMJ Oct 22, 2013 11 studies, 796 patients, BMI 27-53 Surgery superior to med Rx Wt. loss, HbA1c, T2DM remission, TG, HDL, remission of metabolic syndrome, QOL, medication reduction No difference in BP or LDL No CV events or death after surgery Anemia (15%), Reoperation (8%) Surgical vs Medical Treatments for Type 2 Diabetes Mellitus: A Randomized Clinical Trial Anita P.?Courcoulas,?MD, MPH; Bret H.?Goodpaster,?PhD; Jessie K?Eagleton,?MPH; Steven H.?Belle,?PhD, MScHyg; Melissa A.?Kalarchian,?PhD; Wei?Lang,?PhD; Frederico G. S.?Toledo,?MD; John M.?Jakicic,?PhD Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 Diabetes Feasibility and 1-Year Results of a Randomized Clinical Trial Florencia?Halperin,?MD; Su-Ann?Ding,?MD; Donald C.?Simonson,?MD, MPH, ScD; Jennifer?Panosian,?BA; Ann?Goebel-Fabbri,?PhD; Marlene?Wewalka,?MD; Osama?Hamdy,?MD, PhD; Martin?Abrahamson,?MD; Kerri?Clancy,?RN; Kathleen?Foster,?RN; David?Lautz,?MD; Ashley?Vernon,?MD; Allison B.?Goldfine,?MD 2 More Recent RCT’s JAMA Surgery June 4, 2014 Both Show Superiority of Surgery vs. Intensive Medical RX International Diabetes Federation Guidelines Surgery should be an accepted option in people who have type 2 diabetes and BMI of 35 or more Surgery should also be considered as an alternative treatment option in persons with BMI 30 to 35 when diabetes cannot be adequately controlled by optimal medical regimen, especially in the presence of other major cardiovascular disease risk factors In Asian, and some other ethnicities of increased risk, BMI action points may be lower e.g. BMI 27.5 to 32.5 Bariatric Surgical and Procedural Interventions in the Treatment of Obese Patients with Type 2 Diabetes Download at Scientific Organizations with Guidelines/Position Statements that Support Metabolic Surgery for Treating T2DM Organization 2008 2014 National Institutes of Health NIH YES YES Nat

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档